Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate

(2010) Patrick S. Ward et al.   CANCER CELL

Redox Regulation in Cancer: A Double-edged Sword with Therapeutic Potential

(2010) Asha Acharya et al.   Oxidative Medicine and Cellular Longevity

IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors

(2009) Fonnet E. Bleeker et al.   HUMAN MUTATION

RACK1: A superior independent predictor for poor clinical outcome in breast cancer

(2009) Xi-Xi Cao et al.   INTERNATIONAL JOURNAL OF CANCER

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

(2009) Mi Ran Kang et al.   INTERNATIONAL JOURNAL OF CANCER

Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas

(2009) Ryo Nagashio et al.   LUNG CANCER

Identification of Proteomic Differences between Squamous Cell Carcinoma of the Lung and Bronchial Epithelium

(2009) Gereon Poschmann et al.   MOLECULAR & CELLULAR PROTEOMICS

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

(2009) Lenny Dang et al.   NATURE

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

(2009) Dunyaporn Trachootham et al.   NATURE REVIEWS DRUG DISCOVERY

Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

(2009) Elaine R. Mardis et al.   NEW ENGLAND JOURNAL OF MEDICINE

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Protein Expression in Human Non-Small Cell Lung Cancer: A Systematic Database

(2009) Rena Isabel Bührens et al.   PATHOBIOLOGY

Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1 

(2009) S. Zhao et al.   SCIENCE

The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation

(2008) Ralph J. DeBerardinis et al.   Cell Metabolism

Proteomics-driven cancer biomarker discovery: looking to the future

(2008) Richard J Simpson et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67

(2008) Zhi Wang et al.   EUROPEAN JOURNAL OF CANCER

Comparative Proteomics Approach to Screening of Potential Diagnostic and Therapeutic Targets for Oral Squamous Cell Carcinoma

(2008) Zhi Wang et al.   MOLECULAR & CELLULAR PROTEOMICS

Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation

(2008) Giorgia Egidy et al.   Molecular Cancer